A synthetic molecule targeting STAT3 against human oral squamous cell carcinoma cells

被引：0
|
作者：
Bai, Li-Yuan [1 ,2 ]
Dokla, Eman M. E. [3 ]
Chu, Po-Chen [4 ,5 ]
Feng, Chia-Hsien [6 ]
Hu, Jing-Lan [1 ]
Wang, Liang-Jun [7 ]
Weng, Jing-Ru [7 ,8 ,9 ]
机构：
[1] China Med Univ Hosp, Dept Internal Med, Div Hematol & Oncol, Taichung 404, Taiwan
[2] China Med Univ, Coll Med, Taichung 404, Taiwan
[3] Ain Shams Univ, Fac Pharm, Pharmaceut Chem Dept, Cairo 11566, Egypt
[4] China Med Univ, Dept Cosmeceut, Taichung 404, Taiwan
[5] China Med Univ, Grad Inst Cosmeceut, Taichung 404, Taiwan
[6] Kaohsiung Med Univ, Coll Pharm, Dept Fragrance & Cosmet Sci, Kaohsiung 807, Taiwan
[7] Natl Sun Yat Sen Univ, Dept Marine Biotechnol & Resources, Kaohsiung 804, Taiwan
[8] Kaohsiung Med Univ, Grad Inst Nat Prod, Kaohsiung 807, Taiwan
[9] Taipei Med Univ, Grad Inst Pharmacognosy, Coll Pharm, Taipei 110, Taiwan
来源：
INTERNATIONAL JOURNAL OF MEDICAL SCIENCES | 2025年 / 22卷 / 05期
关键词：
Oral squamous cell carcinoma; apoptosis; migration; MAPK; STAT3; TYROSINE KINASE INHIBITOR; EPITHELIAL-MESENCHYMAL TRANSITION; CANCER CELLS; KAPPA-B; GROWTH; RECEPTOR; EXPRESSION; ACTIVATION; PATHWAY; HEAD;
D O I：
10.7150/ijms.105200
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Oral squamous cell carcinoma (OSCC), one of the most common cancers in Taiwan, needs new therapeutic agents and treatments. The aim of this study was to investigate the anti-proliferative activity of nyl]-1,2,4-oxadiazol-3-yl]phenyl]-3-pyridine-carboxamide} (COC), a synthetic molecule, in OSCC cells. COC exhibits potent tumor-suppressive efficacy with IC50 values of 195 nM and 204 nM toward SCC2095 and SCC4 OSCC cells, respectively. Our data revealed that COC caused caspase-dependent apoptosis and downregulated the MAPK signaling pathway. In addition, COC modulated the levels of E-cadherin and beta-catenin and inhibited migration. COC also decreased p-STAT3 levels, and the overexpression of STAT3 partially attenuated COC-induced cytotoxicity. Therefore, our findings suggest the use of COC as a new approach to oral cancer treatment.
引用
收藏
页码：1081 / 1091
页数：11
相关论文
共 50 条
  • [21] Licochalcone C induced apoptosis in human oral squamous cell carcinoma cells by regulation of the JAK2/STAT3 signaling pathway
    Oh, Ha-Na
    Seo, Ji-Hye
    Lee, Mee-Hyun
    Kim, Cheolhee
    Kim, Eunae
    Yoon, Goo
    Cho, Seung-Sik
    Cho, Young Sik
    Choi, Hyun Woo
    Shim, Jung-Hyun
    Chae, Jung-Il
    JOURNAL OF CELLULAR BIOCHEMISTRY, 2018, 119 (12) : 10118 - 10130
  • [22] Active Stat3 is required for survival of human squamous cell carcinoma cells in serum-free conditions
    Weihong Yin
    Satish Cheepala
    Jennifer N Roberts
    Keith Syson-Chan
    John DiGiovanni
    John L Clifford
    Molecular Cancer, 5 (1)
  • [23] Active STAT3 is required for survival of human squamous cell carcinoma cells in serum free conditions.
    Yin, WH
    Roberts, J
    Yang, XL
    Syson-Chan, K
    DiGiovanni, J
    Lippman, SM
    Clifford, JL
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2004, 13 (11) : 1832S - 1832S
  • [24] Active Stat3 is required for survival of human squamous cell carcinoma cells in serum-free conditions
    Yin, Weihong
    Cheepala, Satish
    Roberts, Jennifer N.
    Syson-Chan, Keith
    DiGiovanni, John
    Clifford, John L.
    MOLECULAR CANCER, 2006, 5
  • [25] Effect of targeting Aurora kinase A in human oral squamous cell carcinoma cells
    Tanaka, Hiroshi
    Nakashiro, Koh-ichi
    Oka, Ryota
    Hamakawa, Hiroyuki
    CANCER RESEARCH, 2012, 72
  • [26] Antitumor activity of a novel small molecule STAT3 inhibitor against a human lymphoma cell line with high STAT3 activation
    Ashizawa, Tadashi
    Miyata, Haruo
    Ishii, Hidee
    Oshita, Chie
    Matsuno, Kenji
    Masuda, Yoshiaki
    Furuya, Toshio
    Okawara, Tadashi
    Otsuka, Masami
    Ogo, Naohisa
    Asai, Akira
    Akiyama, Yasuto
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2011, 38 (05) : 1245 - 1252
  • [27] MiR-143 inhibits tumour progression by targeting STAT3 in esophageal squamous cell carcinoma
    Li, B.
    Liu, S. C. H. Et. I. Jia
    Mao, S. C. H. Et. I. Yu
    RADIOTHERAPY AND ONCOLOGY, 2016, 119 : S479 - S479
  • [28] Fucoxanthin inhibits the proliferation and stem cell formation of oral squamous cell carcinoma (OSCC) cells by regulating JAK/STAT3 pathway
    Feng, Xue
    Li, Yu
    Zhang, Lijia
    Sun, Heng
    Liu, Songjiang
    TROPICAL JOURNAL OF PHARMACEUTICAL RESEARCH, 2023, 22 (01) : 9 - 14
  • [29] Dihydroartemisinin as a Putative STAT3 Inhibitor, Suppresses the Growth of Head and Neck Squamous Cell Carcinoma by Targeting Jak2/STAT3 Signaling
    Jia, Lifeng
    Song, Qi
    Zhou, Chenyang
    Li, Xiaoming
    Pi, Lihong
    Ma, Xiuru
    Li, Hui
    Lu, Xiuying
    Shen, Yupeng
    PLOS ONE, 2016, 11 (01):
  • [30] Stat3 as a molecular target in RNA interference-based treatment of oral squamous cell carcinoma
    Klosek, Sebastian Krystian
    Nakashiro, Koh-Ichi
    Hara, Shingo
    Goda, Hiroyuki
    Hamakawa, Hiroyuki
    ONCOLOGY REPORTS, 2008, 20 (04) : 873 - 878
12345